SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹627 Cr | ₹559 Cr | ₹537 Cr | ₹513 Cr | ₹515 Cr |
What is the latest Total Current Liabilities ratio of SEQUENT SCIENTIFIC ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹627 Cr |
Mar2023 | ₹559 Cr |
Mar2022 | ₹537 Cr |
Mar2021 | ₹513 Cr |
Mar2020 | ₹515 Cr |
How is Total Current Liabilities of SEQUENT SCIENTIFIC Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹627 Cr | 12.21 | |
Mar2023 | ₹559 Cr | 3.98 | |
Mar2022 | ₹537 Cr | 4.72 | |
Mar2021 | ₹513 Cr | -0.34 | |
Mar2020 | ₹515 Cr | - |
Compare Total Current Liabilities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹3,541.7 Cr | -8.7% | -9.7% | 14.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,213.0 Cr | 3.9% | -3.2% | 3.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,403.0 Cr | 1.8% | -4.5% | 53.9% | Stock Analytics | |
CIPLA | ₹117,415.0 Cr | -0.6% | -0.3% | -2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹104,791.0 Cr | 1.2% | -3% | 14.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,228.2 Cr | -3% | -9.5% | -11.7% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | -8.7% |
-9.7% |
14.9% |
SENSEX | 0.4% |
-4.9% |
-0.1% |
You may also like the below Video Courses